• Home
  • News
  • Analysis
  •  
    Regions
    • Australasia
    • Southeast Asia
    • Greater China
    • North Asia
    • South Asia
    • North America
    • Europe
    • Central Asia
    • MENA
  •  
    Funds
    • LPs
    • Buyout
    • Growth
    • Venture
    • Renminbi
    • Secondary
    • Credit/Special Situations
    • Infrastructure
    • Real Estate
  •  
    Investments
    • Buyout
    • Growth
    • Early stage
    • PIPE
    • Credit
  •  
    Exits
    • IPO
    • Open market
    • Trade sale
    • Buyback
  •  
    Sectors
    • Consumer
    • Financials
    • Healthcare
    • Industrials
    • Infrastructure
    • Media
    • Technology
    • Real Estate
  • Events
  • Chinese edition
  • Data & Research
  • Weekly Digest
  • Newsletters
  • Sign in
  • Events
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)870 240 8859

      Email: customerservices@incisivemedia.com

      • Sign in
     
      • Saved articles
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • RSS
    • Twitter
    • LinkedIn
    • Newsletters
  • Free Trial
  • Subscribe
  • Weekly Digest
  • Chinese edition
  • Data & Research
    • Latest Data & Research
      2023-china-216x305
      Regional Reports

      The reports review the year's local private equity and venture capital activity and are filled with up-to-date data and intelligence on fundraising, investments, exits and M&A. The regional reports also feature information on key companies.

      Read more
      2016-pevc-cover
      Industry Review

      Asian Private Equity and Venture Capital Review provides an independent overview of the private equity, venture capital and M&A activities in the Asia region. It delivers insights on investments made, capital raised, sector specific figures and more.

      Read more
      AVCJ Database

      AVCJ Database is the ultimate link between Asian dealmakers and those who provide advisory, financial, legal and technological services to the private equity, venture capital and M&A industries. It is packed with facts and figures on more than 153,000 companies and almost 117,000 transactions.

      Read more
AVCJ
AVCJ
  • Home
  • News
  • Analysis
  • Regions
  • Funds
  • Investments
  • Exits
  • Sectors
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)870 240 8859

    Email: customerservices@incisivemedia.com

    • Sign in
 
    • Saved articles
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Qianhai FoF

healthcare-lab-pharma-drug-biotech
CICC leads $60m Series B for China's Grit Biotechnology

CICC Capital had led a USD 60m Series B round for Grit Biotechnology, a Shanghai-based drug developer that is working on pioneering cancer treatments involving tumour-infiltrating lymphocytes (LIT).

  • Greater China
  • 11 September 2023
hospital-operation-surgery-healthcare-equipment
PE-backed Lu Daopei Medical files for Hong Kong IPO

Lu Daopei Medical Group Holding, which runs a network of hospitals in China that specialise in the treatment of blood diseases, has filed for a Hong Kong IPO.

  • Greater China
  • 10 July 2023
eye-closeup
China Life, Qianhai Ark back ophthalmic device maker

China Life Private Equity and Shenzhen-based Qianhai Ark have led a CNY 300m (USD 44m) Series C round for Svision Imaging, a China-based ophthalmic device manufacturer.

  • Greater China
  • 10 March 2023
car-ev-electric-vehicle-factory-automotive-china-2
China EV maker Hozon completes Series D with $443m tranche

Hozon Auto, a Chinese electric vehicle (EV) manufacturer, has raised CNY 3bn (USD 443m) in funding from the likes of Shenzhen Capital Group, Qianhai FoF, Hongtai Capital, Dayone Capital, Insight Capital, and Dianshi Capital.

  • Greater China
  • 22 July 2022
gogox-ipo
PE-backed Gogox sinks on debut after $98m Hong Kong IPO

Gogox, a last-mile logistics company formed through the merger of Hong Kong's GoGoVan and an affiliate of mainland China-based 58.com, fell 22% on its Hong Kong trading debut following a HKD 771.4 (USD 98.3m) IPO.

  • Greater China
  • 27 June 2022
pills-drugs-pharma-3
China medtech start-up SiBionics raises $79m

China-based medical technology start-up SiBionics has raised CNY 500m (USD 79m) in a third tranche of Series C funding co-led by CPE and China Life Investment.

  • Greater China
  • 25 January 2022
ecommerce-online-shopping-9
Vision Fund leads $150m round for China e-commerce enabler

Shoplazza, a China-based software-as-a-service (SaaS) provider specialising in cross-border e-commerce, has raised USD 150m in the first tranche of Series C led by SoftBank Vision Fund II.

  • Greater China
  • 24 January 2022
chip-semiconductor-circuit-lab
China GPU chip designer secures $313m Series A

Moore Threads, a Chinese chip designer established 13 months ago by a team from Nvidia, has closed Series A at RMB2 billion ($313 million) led by Shanghai Guosheng Capital, 5Y Capital, and a BOC International fund.

  • Greater China
  • 26 November 2021
China networking chip specialist Clounix raises $63m

China-based networking chip manufacturer Clounix has raised approximately RMB400 million ($63 million) across angel and pre-Series A rounds.

  • Greater China
  • 26 October 2021
Hong Kong's GoGoVan raises $250m

Hong Kong-based last-mile logistics company GoGoVan has raised $250 million from a group of investors led by China’s InnoVision Capital.

  • Greater China
  • 16 July 2018
China's CMAB Biopharma gets $34m Series B

CD Capital, a Chinese healthcare-focused VC also known as CDBI Partners, has led a $34 million Series B round for CMAB Biopharma, a manufacturing services provider for biologic product developers.

  • Greater China
  • 04 April 2018
Tech firms, state-backed funds in $12b China Unicom deal

State-owned telecom group China Unicom said it will raise RMB78 billion ($12 billion) from private and state investors – including domestic technology companies, Qianhai FoF and China Structural Reform Fund – in response to the government’s mixed-ownership...

  • Greater China
  • 18 August 2017
Renminbi fundraising: Policy power

The launch of several huge government-backed funds has skewed renminbi-denominated fundraising in China. What does their arrival mean for valuations and for the nascent independent LP community?

  • Greater China
  • 08 February 2017
  • About AVCJ
  • Advertise
  • Contacts
  • About ION Analytics
  • Terms of use
  • Privacy policy
  • Group disclaimer
  • RSS
  • Twitter
  • LinkedIn
  • Newsletters

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013